Interpretation and integration of the federal substance use privacy protection rule in integrated health systems: A qualitative analysis.
Abstract
BACKGROUND:Federal regulations (42 CFR Part 2) provide special privacy protections
for persons seeking treatment for substance use disorders. Primary care providers,
hospitals, and health care organizations have struggled to balance best practices
for medical care with adherence to 42 CFR Part 2, but little formal research has examined
this issue. The aim of this study was to explore institutional variability in the
interpretation and implementation of 42 CFR Part 2 regulations related to health systems
data privacy practices, policies, and information technology architecture. METHODS:This
was a cross-sectional qualitative study using purposive sampling to conduct interviews
with privacy/legal officers (n = 17) and information technology specialists (n = 10)
from 15 integrated healthcare organizations affiliated with three research nodes of
the National Institute on Drug Abuse (NIDA) National Drug Abuse Treatment Clinical
Trials Network (CTN). Trained staff completed a short survey and digitally recorded
semi-structured qualitative interview with each participant. Interviews were transcribed
and coded within Atlas.ti. Framework analysis was used to identify and organize key
themes across selected codes. RESULTS:Participants voiced concern over balancing patient
safety with 42 CFR Part 2 privacy protections. Although similar standards of protection
regarding release of information outside of the health system was described, numerous
workarounds were used to manage intra-institutional communication and care coordination.
To align 42 CFR Part 2 restrictions with electronic health records, health systems
used sensitive note designation, "break the glass" technology, limited role-based
access for providers, and ad hoc solutions (e.g., provider messaging). CONCLUSIONS:In
contemporary integrated care systems, substance-related EHR records (e.g., patient
visit history, medication logs) are often accessible internally without specific consent
for sharing despite the intent of 42 CFR Part 2. Recent amendments to 42 CFR Part
2 have not addressed information sharing needs within integrated care settings.
Type
Journal articlePermalink
https://hdl.handle.net/10161/19924Published Version (Please cite this version)
10.1016/j.jsat.2018.11.005Publication Info
Campbell, Aimee NC; McCarty, Dennis; Rieckmann, Traci; McNeely, Jennifer; Rotrosen,
John; Wu, Li-Tzy; & Bart, Gavin (2019). Interpretation and integration of the federal substance use privacy protection rule
in integrated health systems: A qualitative analysis. Journal of substance abuse treatment, 97. pp. 41-46. 10.1016/j.jsat.2018.11.005. Retrieved from https://hdl.handle.net/10161/19924.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Li-Tzy Wu
Professor in Psychiatry and Behavioral Sciences
Education/Training: Pre- and post-doctoral training in mental health service research,
psychiatric epidemiology (NIMH T32), and addiction epidemiology (NIDA T32) from Johns
Hopkins University School of Public Health (Maryland); Fellow of the NIH Summer Institute
on the Design and Conduct of Randomized Clinical Trials.Director: Duke Community Based
Substance Use Disorder Research Program.Research interests: COVID-19, Opioid misuse,
Opioid overdose, Opioid use disorder

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info